Displaying drugs 2926 - 2950 of 3204 in total
3-(INDOL-3-YL) LACTATE
Experimental
Vixotrigine
Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.
Investigational
Brefeldin A
A metabolite from Penicillium brefeldianum that exhibits a wide range of antibiotic activity.
Experimental
7,8-dihydro-7,7-dimethyl-6-hydroxypterin
Experimental
Triacetylchitotriose
Experimental
5,10-Methylene-6-Hydrofolic Acid
Experimental
5'-O-(L-Prolylsulfamoyl)adenosine
Experimental
CP-320626
Experimental
Carboxymycobactin T
Experimental
Sp-722
Experimental
Ciluprevir
The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans.
Investigational
ALK-4290
ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).
Investigational
Cinolazepam
Cinolazepam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. It is not approved in Canada or America.
Experimental
Ginsenoside C
Nutraceutical
Sabarubicin
Sabarubicin has been used in trials studying the treatment of Prostate Cancer, Testicular Germ Cell Tumor, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Vincamine
Vincamine is a monoterpenoid indole alkaloid obtained from the leaves of Vinca minor with a vasodilatory property. Studies indicate that vincamine increases the regional cerebral blood flow.
Experimental
Beta-D-Glucopyranose Spirohydantoin
Experimental
N-acetyl-D-glucosamine-6-phosphate
Experimental
Displaying drugs 2926 - 2950 of 3204 in total